Glutathione S-Transferase M1 Gene Polymorphism and Laryngeal Cancer Risk: A Meta-Analysis

被引:7
作者
Ying, Xin-Jiang [1 ]
Dong, Pin [1 ]
Shen, Bin [1 ]
Xu, Cheng-Zhi [1 ]
Xu, Hong-Ming [1 ]
Zhao, Shu-Wei [2 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Otolaryngol Head & Neck Surg, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China
[2] Second Mil Med Univ, Dept Otolaryngol, Changzheng Hosp, Shanghai, Peoples R China
来源
PLOS ONE | 2012年 / 7卷 / 08期
关键词
SQUAMOUS-CELL CARCINOMA; GSTM1; POLYMORPHISMS; NAT2; T1; GENOTYPES; LUNG-CANCER; GSTT1; TOBACCO; CYP1A1; HEAD; ALCOHOL;
D O I
10.1371/journal.pone.0042826
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Objectives: Studies investigating the association between glutathione S-transferase M1 (GSTM1) gene polymorphism and laryngeal cancer risk have reported conflicting results. The aim of the present study was to conduct a meta-analysis assessing the possible associations of GSTM1 gene polymorphism with laryngeal cancer risk. Methods: The relevant studies were identified through a search of PubMed, Embase, ISI Web of Knowledge and Chinese National Knowledge Infrastructure until May 2011 and selected on the basis of the established inclusion criteria for publications, then a meta-analysis was performed to quantitatively summarize association of GSTM1 polymorphism with laryngeal cancer susceptibility. Results: Seventeen studies were included in the present meta-analysis (2,180 cases and 2,868 controls). The combined results based on all studies showed that GSTM1 null genotype was associated with increased laryngeal cancer risk (OR = 1.17, 95% CI = 1.04 similar to 1.31). When stratifying for race, GSTM1 null genotype exhibited increased laryngeal cancer risk in Caucasians (OR = 1.15, 95% CI = 1.01 similar to 1.31), while no significant association was detected in Asians (OR = 1.25, 95% CI = 0.80 similar to 1.96). In the subgroup analysis based on source of controls, significant associations were observed in the population-based studies (OR = 1.15, 95% CI = 1.01 similar to 1.31) yet not in the hospital-based studies (OR = 1.25, 95% CI = 0.93 similar to 1.67). Furthermore, in the subgroup analysis based on sample size, significant associations were also found in studies with at least 50 cases and 50 controls (OR = 1.15, 95% CI = 1.02 similar to 1.30) but not in studies with fewer than 50 cases or 50 controls (OR = 1.46, 95% CI = 0.87 similar to 2.46). Conclusions: This meta-analysis supported that the GSTM1 gene polymorphism was associated with laryngeal cancer, particularly in Caucasians, and these associations varied in different subgroup, which indicated that population-based study with larger sample size was more appropriate in design of future study.
引用
收藏
页数:7
相关论文
共 44 条
[1]   Relation of glutathione S-transferase genotypes (GSTM1 and GSTT1) to laryngeal squamous cell carcinoma risk [J].
Acar, Hasan ;
Ozturk, Kayhan ;
Muslumanoglu, M. Hamza ;
Yildirim, M. Selman ;
Cora, Tulin ;
Cilingir, Oguz ;
Ozer, Bedri .
CANCER GENETICS AND CYTOGENETICS, 2006, 169 (02) :89-93
[2]   Relationship of tobacco smoking with GSTM1 gene polymorphism in laringeal cancer [J].
Bardakci, F ;
Canbay, E ;
Degerli, N ;
Coban, L ;
Canbay, E .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2003, 7 (03) :307-312
[3]   Occupation, exposure to polycyclic aromatic hydrocarbons and laryngeal cancer risk [J].
Becher, H ;
Ramroth, H ;
Ahrens, W ;
Risch, A ;
Schmezer, P ;
Dietz, A .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (03) :451-457
[4]   OPERATING CHARACTERISTICS OF A BANK CORRELATION TEST FOR PUBLICATION BIAS [J].
BEGG, CB ;
MAZUMDAR, M .
BIOMETRICS, 1994, 50 (04) :1088-1101
[5]   Capture-recapture is a potentially useful method for assessing publication bias [J].
Bennett, DA ;
Latham, NK ;
Stretton, C ;
Anderson, CS .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (04) :349-357
[6]   CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer [J].
Boccia, Stefania ;
Cadoni, Gabriella ;
Sayed-Tabatabaei, Fakhredin A. ;
Volante, Mariangela ;
Arzani, Dario ;
De lauretis, Angelo ;
Cattel, Caterina ;
Almadori, Giovanni ;
Van Duijn, Cornelia M. ;
Paludetti, Gaetano ;
Ricciardi, Gualtiero .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (01) :93-100
[7]   Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology [J].
Bolt, H. M. ;
Thier, R. .
CURRENT DRUG METABOLISM, 2006, 7 (06) :613-628
[8]   Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy [J].
Cabelguenne, A ;
Loriot, MA ;
Stucker, I ;
Blons, H ;
Koum-Besson, E ;
Brasnu, D ;
Beaune, P ;
Laccourreye, O ;
Laurent-Puig, P ;
De Waziers, I .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (05) :725-730
[9]   Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: A literature-based systematic HuGE review and meta-analysis [J].
Carlsten, C. ;
Sagoo, G. S. ;
Frodsham, A. J. ;
Burke, W. ;
Higgins, J. P. T. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (07) :759-774
[10]   GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms in laryngeal squamous cell carcinoma in a Greek population [J].
Chatzimichalis, M. ;
Xenellis, J. ;
Tzagaroulakis, A. ;
Sarof, P. ;
Banis, K. ;
Gazouli, M. ;
Bibas, A. .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2010, 124 (03) :318-323